Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 18
  • Journal CiteScore: 5.91
  • Journal Impact Factor: 4.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
Share This Page


Advancements in Translational Biomedical Research

Patil A

The aim of Translational biomedicine is to promote basic scientific research for the well-being of humankind. The scientific discipline of Translational medicine encourages the research towards therapeutic interventions which not only brings forward the possible therapeutics but also highlights the research gaps in research specific area. The Issue 3 Volume 11 of Translational Biomedicine showcases a wide range of studies such as the usage of plant phytoderivatives as fusion inhibitors targeting the spike proteins in order to inhibit the entry of COVID-19, role of stem cells in Chronic myeloid leukaemia, the effect of Avastin for the treatment of Neovascular Age related Macular Degeneration.